Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Collaborative and Cybridi to Co-Develop Breast Cancer Tissue Array

NEW YORK, April 6 (GenomeWeb News) - Genomics Collaborative and Cybrdi will co-develop a breast tumor tissue microarray, the companies said today.


The arrays will be accompanied by clinical data on the molecular factors of the tissue to "establish correlations between the severity of the disease, responses to treatments, and the presence of certain biomarkers," Larry Liu, president and CEO of Cybrdi, said in the statement. "It can be expanded to other types of malignancies, including colon, lung, and brain tumors."


Genomics Collaborative, a division of SeraCare Life Science, is providing tissue from its GC Global Repository samples, which are linked to clinical, demographic, and treatment data.


"We hope to generate additional tumor-specific tissue arrays that look at the tissue's response to treatment," said Kevin Krenitsky, Genomics Collaborative senior vice president, in the statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.